The role of the G protein gamma(2) subunit in opioid antinociception in mice |
| |
Authors: | Hosohata K Logan J K Varga E Burkey T H Vanderah T W Porreca F Hruby V J Roeske W R Yamamura H I |
| |
Affiliation: | Departments of Pharmacology, Chemistry, Biochemistry, Psychiatry, Medicine and the Program in Neuroscience, University of Arizona, Tucson, AZ 85724, USA. |
| |
Abstract: | We examined the role of the gamma(2) subunit of G proteins (Ggamma(2)) in the antinociception produced by c[D-Pen(2), D-Pen(5)]enkephalin (DPDPE) in mice. DPDPE produced 84.0+/-9.0% antinociception in vehicle-treated mice. After intracerebroventricular (i.c.v.) treatment with an antisense phosphorothioate oligodeoxynucleotide to the Ggamma(2) subunit, DPDPE-mediated antinociception decreased to 24.4+/-7.4%. The mismatch phosphorothioate oligodeoxynucleotide-treated mice showed 65.1+/-10.3% antinociception, while the missense phosphorothioate oligodeoxynucleotide-treated mice showed 76.4+/-23.6% antinociception by DPDPE. The reduction of analgesia in antisense phosphorothioate oligodeoxynucleotide-treated mice was significant in comparison with vehicle-treated (P<0.001), mismatch phosphorothioate oligodeoxynucleotide-treated (P<0.01) and missense phosphorothioate oligodeoxynucleotide-treated (P<0.05) mice. These results suggest that the G protein gamma(2) subunit is involved in the transduction pathway leading to antinociception by DPDPE. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|